Non-Invasive Liquid Biopsy to Help Cancer Diagnosis Gets CE Certification
![]() |
LONDON, March 11, 2021 /PRNewswire/ -- Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management.
TruBlood is a blood-based, non-invasive test for diagnostic...
Read more: Non-Invasive Liquid Biopsy to Help Cancer Diagnosis Gets CE Certification